NVCR insider update: officer holds 347,745 shares after withholding
Rhea-AI Filing Summary
NovoCure Ltd (NVCR) reported an insider transaction on a Form 4. The company’s officer, EVP, President, Novocure Oncology, had 966 ordinary shares withheld on 11/01/2025 at $12.81 per share to satisfy tax obligations upon the vesting of Restricted Stock Units (transaction code F).
Following this non-discretionary withholding, the officer beneficially owns 347,745 shares, held directly. The filing indicates it was made by one reporting person.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 966 shares
Net Sell
1 txn
Insider
Leonard Frank X
Role
EVP, Pres., Novocure Oncology
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Ordinary Shares | 966 | $12.81 | $12K |
Holdings After Transaction:
Ordinary Shares — 347,745 shares (Direct)
Footnotes (1)
- F1. Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).
FAQ
What did NVCR disclose in this Form 4?
An officer had 966 shares withheld at $12.81 on 11/01/2025 to cover taxes from RSU vesting (code F).
Who is the reporting person in NVCR’s Form 4?
An officer of NovoCure, titled EVP, President, Novocure Oncology.
What does transaction code F mean on the NVCR Form 4?
Code F indicates shares were withheld to pay taxes related to an equity award vesting.
Was this NVCR Form 4 filed by multiple persons?
No. It was filed by one reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.